The NARLAL2 dose escalation trial: dosimetric implications of inter-fractional changes in organs at risk.
CONCLUSIONS: Anatomical changes during radiotherapy caused one or more OAR constraint violations for approximately half of the patient cohort. The main cause was tumour shrinkage. For lung cancer radiotherapy dose escalation trials, we recommend incorporation of adaptive radiotherapy strategies.
PMID: 28830293 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Hoffmann L, Knap MM, Khalil AA, Lutz CM, Sloth Møller D Tags: Acta Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Denmark Health | Esophagus Cancer | Heart | Lung Cancer | Oesophagus | PET Scan | Study | Tracheal Cancer